August 31, 2017
The Chase Group announces our newest search engagement with OncoQuest. OncoQuest is expanding and The Chase Group has been retained to recruit talent for this stage of their growth. Our firm will be exclusively recruiting a new Chief Medical Officer, Head of Regulatory Affairs, and a Director of Clinical Operations/Clinical Research. OncoQuest is a clinical stage company, focused on combinatorial immunotherapeutic approaches to cancer by using either immunoglobulin G or E (IgG or IgE) and chemotherapy or immune-adjuvant or photodynamic therapy to enhance tumor specific immunity and clinical outcomes. To learn more, contact ken@thechasegroup.com.
